Systane Clinical Experience Study

Phase 4

Completed

• Conditions: Dry Eye Syndrome
• Interventions: Other: Systane

• Registration Number: NCT00818909
• Lead Sponsor: Alcon Research

Brief Summary

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-01
• Study First Submitted: 2009-01-07
• Study First Submitted QC: 2009-01-07
• Study First Posted: 2009-01-08
• Primary Completion: 2009-10
• Study Completion: 2009-10
• Status Verified: 2012-01
• Last Update Submitted: 2012-01-31
• Last Update Posted: 2012-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 941

Inclusion Criteria

• moderate to severe dry feeling eyes

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Systane	Systane	Systane ocular product

Primary Outcome Measures

Name	Time	Method
corneal and conjunctiva staining score	4 weeks

Secondary Outcome Measures

Name	Time	Method
Tear film break up time	4 weeks